MDXG FY 2018 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$359M+11.8% YoY

Gross Profit

$323M89.9% margin

Operating Income

-$4M-1.1% margin

Net Income

-$30M-8.3% margin

EPS (Diluted)

$-0.28

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$26M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$123M

Total Liabilities

$73M

Stockholders' Equity

$50M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$359M	$321M	+11.8%
Gross Profit	$323M	$286M	+12.9%
Operating Income	-$4M	$46M	-108.5%
Net Income	-$30M	$65M	-146.3%